Abivax (ABVX) Shareholder's Equity (2023 - 2026)
Abivax (ABVX) Shareholder's Equity (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shareholder's Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | 7.14 Bn |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | 795.79 Mn |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 595,226.00 |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 14.38 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 19.36 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 502.95 Mn |
| 10 | Regeneron Pharmaceuticals | 66.09 Bn | 57.33 Bn | 3.31 Bn | 31.42 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 502.95 Mn |
| Dec 31, 2025 | 529.88 Mn |
| Sep 30, 2025 | 597.67 Mn |
| Jun 30, 2025 | -54.65 Mn |
| Mar 31, 2025 | -6.93 Mn |
| Dec 31, 2024 | 43.38 Mn |
| Jun 30, 2024 | 136.19 Mn |
| Dec 31, 2023 | 210.89 Mn |